Akili Grabs CE Mark for Children’s Digital ADHD Treatment

Massachusetts-based Akili Interactive has obtained the CE mark in Europe for its EndeavorRx software for treatment of attention deficit hyperactivity disorder (ADHD) in children.

The prescription-only product uses a video game-like format to stimulate the neural systems that control attention. The software includes algorithms that personalize the treatment for each child.

The FDA last week cleared EndeavorRx for marketing in the U.S.